Glacier Peak Capital’s Gilead Sciences GILD Stock Holding History

Glacier Peak Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,680	Closed	-$1.34M	–	57
2016 Q4	$1.34M	Buy	+18,680	New	+$1.39M	0.77%	39

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Glacier Peak Capital's GILD Position: Q1 2017 in Review

Glacier Peak Capital sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 18,680 shares — an estimated $1.34M sold.

Glacier Peak Capital first reported a position in GILD in Q4 2016 and held it in 1 quarter. The position peaked at $1.34M in Q4 2016. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Glacier Peak Capital reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Glacier Peak Capital sold 18,680 Gilead Sciences shares in Q1 2017, an estimated $1.34M.
Glacier Peak Capital first reported a position in Gilead Sciences in Q4 2016 and held it in 1 quarter.
Glacier Peak Capital's Gilead Sciences position peaked at $1.34M in Q4 2016.
1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Glacier Peak Capital's 13F filing for Q1 2017, filed 12 May 2017.